NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Saturday, May 18, 2024 9:13

Release 2.84
Solacyl® 1000 mg/g Powder for Use in Drinking Water for Turkeys
 
Species: Turkeys
Therapeutic indication: Pharmaceuticals: Anti-inflammatory preparations: Oral: Other NSAIDs
Active ingredient: Sodium Salicylate
Product:Solacyl® 1000 mg/g Powder for Use in Drinking Water for Turkeys
Product index: Solacyl 1000 mg/g Powder for Use in Drinking Water for Turkeys
Poultry - meat: Meat and offal: 2 days
Withdrawal notes: Not for use in birds producing or intended to produce eggs for human consumption.
Incorporating:
Qualitative and quantitative composition
Each g contains: Active substance:
Sodium salicylate 1000 mg, corresponding to 862.6 mg salicylic acid (as sodium salt)
Pharmaceutical form
Powder for use in drinking water. White to off-white flakes.
Clinical particulars
Target species
Turkeys.
Indications for use
Symptomatic treatment of inflammatory respiratory diseases, if necessary in combination with an appropriate anti-infective therapy.
Contraindications
Do not use in cases of known hypersensitivity to the active substance.
Do not use in case of severe liver and kidney disorders.
Do not use in case of gastrointestinal ulcerations and chronic gastrointestinal disorders.
Special warnings for each target species
The compatibility of the product with other veterinary medicinal products when administered via the drinking water has not been investigated. If used concurrently, the stability and/or solubility of the veterinary medicinal products may change. Therefore, it is recommended that methods or routes of administration other than via drinking water are used to deliver concurrent anti-infective therapy, if needed.
Special precautions for use in animals
Diseased animals may show altered intake of drinking water or feed. In cases of altered drinking water intake, the concentration of the veterinary medicinal product has to be adjusted to ensure the intake of the required dose.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
People with known hypersensitivity (allergies) to sodium salicylate or related substances (eg aspirin) should avoid contact with the product.
Irritation of the skin, eyes, and respiratory tract may occur in the case of accidental contact. Direct contact of the skin and eyes with the medicated water or the powder, and inhalation of the powder should be avoided. It is recommended to wear protective gloves (eg rubber or latex), safety glasses, and an appropriate dust mask (eg disposable half-mask respirator conforming to European Standard EN149). Swelling of the face, lips or eyes or difficulty in breathing are serious symptoms that require immediate medical attention.
In case of accidental dermal exposure, wash skin immediately with water.
In the event of accidental eye contact, wash the eye with plenty of water for 15 minutes, and seek medical advice if irritation persists and show the label to the physician.
Adverse reactions
Turkeys:
Undetermined frequency (cannot be estimated from the available data)
Gastrointestinal irritationa (Tarry or black stoolb ) Drinking a lotc
a especially in animals with pre-existing gastrointestinal disease.
b due to bleeding in the gastrointestinal tract.
c increase in water intake.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for contact details.
Use during pregnancy and lactation
Laying birds:
Laboratory studies in rats have shown evidence of teratogenic and foetotoxic effects.
The use is not recommended during lay.
Interactions
Concurrent administration of potentially nephrotoxic drugs (eg aminoglycosides) should be avoided.
Salicylic acid is highly plasma (albumin) bound and competes with a variety of compounds (eg sulfonamides, ketoprofen) for plasma protein binding sites.
Concurrent use with other non-steroid anti-inflammatory drugs (NSAIDs) is not recommended, because of increased risk of gastro-intestinal disturbances.
Amounts to be administered and administration route
In-drinking water use.
86,2 mg salicylic acid/kg body weight daily (equivalent to100 mg product/kg body weight daily) for 3 consecutive days.
Based on the recommended dose and the number and weight of animals to be treated, the exact daily concentration of the veterinary medicinal product should be calculated according to the following formula:
100 mg veterinary medicinal product/kg body weight/day
x average body weight (kg) of animals to be treated
________________________________________________________________
=
___ mg veterinary medicinal product per
litre of drinking water
Average daily water consumption (l/animal)
The maximum solubility of the veterinary medicinal product in drinking water is approximately 100 g/litre.
For weighing the calculated amount of sodium salicylate the use of suitably calibrated weighing equipment is recommended.
Medicated drinking water should be freshly prepared every 24 hours.
Any medicated water which is not consumed within 24 hours should be discarded and the medicated drinking water replenished.
In order to ensure consumption of the medicated water, animals should not have access to other water supplies whilst being on treatment.
Overdose
The administration of four times the recommended dose resulted in an increase in drinking water consumption and occasional diarrhoea.
Withdrawal periods
Meat and offal: 2 days.
Not for use in birds producing or intended to produce eggs for human consumption.
Pharmacological particulars
Pharmacotherapeutic group: sodium salicylate
ATCvet code: QN02BA04
Pharmacodynamic properties
Sodium salicylate is a NSAID and has an anti-inflammatory effect. The mode of action is based on inhibition of the enzyme cyclooxygenase, resulting in decreased production of prostaglandin (inflammation mediators).
Pharmacokinetic properties
In turkeys, orally administered sodium salicylate is absorbed by passive diffusion partially from the stomach and mainly from the small intestine. The passage through the crop influences the absorption rate and initial sodium salicylate plasma levels depend on how full the crop is. After administration into the crop maximum plasma concentrations are reached in approximately three hours (average), t1/2 is approximately two hours. When dosed orally via the drinking water (dose of 100 mg/kg body weight per day for three days) average plasma concentrations above 20 μg/ml are achieved.
Sodium salicylate distributes very well to the various tissues; the highest concentrations are reached in the liver, kidneys and lungs. Accumulation in inflammatory exudate could be detected. Further studies on metabolism are not available for the turkey. Excretion is probably primarily renal.
Pharmaceutical particulars
Incompatibilities
In the absence of compatibility studies this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years.
Shelf life after first opening the immediate packaging: 6 months.
Shelf life after reconstitution in drinking water according to directions: 24 hours.
After this period, remaining unused solution should be discarded.
Special precautions for storage
This veterinary medicinal product does not require any special temperature storage conditions.
Keep the bag tightly closed after first opening in order to protect from light and moisture.
Immediate packaging
Bags consisting of the following materials: an outer layer of polyethylene terephthalic acid, inside layers of aluminium and polyamide and an inner layer of polyethylene (PET/ALU/PA/PE).
Pack sizes are 100 g, 250 g, 500 g, 1 kg, 2.5 kg and 5 kg.
Not all pack sizes may be marketed.
Disposal
Medicines should not be disposed of via wastewater or household waste.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Marketing Authorisation Holder (if different from distributor)
Eurovet Animal Health BV, Handelsweg 25, 5531 AE Bladel, The Netherlands.
Marketing Authorisation Number
GB: Vm 16849/5003
NI: Vm 16849/3003
Significant changes
Date of the first authorisation or date of renewal
5 October 2017
Date of revision of the text
September 2023
Any other information
For animal treatment only. To be supplied only on veterinary prescription. Keep out of the sight and reach of children.
Legal category
Legal category: POM-V
GTIN
GTIN description:Solacyl 1000 mg/g Powder for Use in Drinking Water for Turkeys 1 kg:
GTIN:08714225161386